LAKE FOREST, Ill.--(BUSINESS WIRE)--Dec. 11, 2017--
IDEX Corporation (NYSE:IEX) announced today the acquisition of thinXXS
Microtechnology AG; a leader in the design, manufacture, and sale of
microfluidic components serving the point of care, veterinary, and life
science markets.
Located in Zweibrücken, Germany, thinXXS will operate within IDEX Health
& Science LLC, part of IDEX’s Health and Science Technologies (HST)
segment.
Commenting on the acquisition, IDEX Chairman and Chief Executive Officer
Andy Silvernail stated, “thinXXS represents our second acquisition in
this space, and with the addition of their advanced technology, our
combination makes IDEX Health and Science the market leader in
microfluidic technology. thinXXS’ product portfolio is a fantastic fit
with IDEX’s core optics and scientific fluidics products and
technologies that serve our life science customers. We look forward to
thinXXS joining IDEX and we believe the transaction will accelerate our
growth prospects in the life science, veterinary and point of care
markets.”
About IDEX
IDEX is a global fluidics leader serving high growth specialized
markets. We are best known for our expertise in highly engineered
fluidics systems and components, as well for our expertise in fire and
safety products including the Jaws of Life® family of rescue and
recovery tools. Our products touch lives every day. Whether it’s a
life-saving rescue operation, dispensing fresh juice to a first grader
or fueling aircraft, IDEX is a leader in creating enabling technology
used in many of the most common everyday activities. For more
information, please visit www.idexcorp.com
IDEX shares are traded on the New York Stock Exchange under the symbol
“IEX”.
View source version on businesswire.com: http://www.businesswire.com/news/home/20171211005555/en/
Source: IDEX Corporation
IDEX Corporation
William K. Grogan, +1-847-498-7070
Senior
Vice President
Chief Financial Officer